Claes Henning New Scientific Advisor to IDL Biotech AB

IDL Biotech continues to strengthen its scientific knowledge by appointing an additional experienced scientific advisor. Read more here.    

 

IDL will participate at MEDICA, the world’s largest event for the medical sector. Medica is held 13-16 November, 2017, in  Düssseldorf, Germany. You will find us in Hall 3A, booth D28.

IDL will also participate in the Swedish Association of Urology in Gothenburg, Sweden October 4-6, 2017.

 

 Patent approved in China

During 2015 the patent  ”Method for detection of cytokeratin 8, 18 and/or 19 and/or soluble fragments thereof” was approved in Sweden. The patent has now been approved in China and is valid until 2034. Read more here

 

Positive results for UBC® Rapid

- UBC® Rapid is recommended to be added in the diagnostics of high grade bladder cancer tumours in a German multicenter study. Read more here 
- Positive results for UBC® Rapid in a Swedish multicenter study. Read more here

 

 Positive results for UBC® Rapid in an

Austrian study

Read the news  here


Oncology products

Cytokeratin Tumor markers

> TPS®

MonoTotal®

TPAcykTM

UBC®

Bacteriology products

Detection of acute typhoid fever

TUBEX® TF